where do you inject pt141 PT-141 Injections Unlocking the Benefits of PT-141

Methods: We developed a biomimetic autophagy degradation peptide (MNP-PDL1) using the lysosomal autophagy system in conjunction with biomimetic membrane technology, which consists of a PD-L1-binding sequence, a PEG3 linker, and a target lysosomal chaperone protein recognition sequence (CIP), which can localize the target protein, PD-L1, to the lysosome for degradation

J Pediatr 108:942945 Connelly A, Cross JH, Gadian DG, Hunter JV, Kirkham FJ, Leonard JV (1993) Magnetic resonance spectroscopy shows increased brain glutamine in ornithine carbamoyl transferase deficiency

Smyth et al., 2018

Our solutions extend across the healthcare ecosystem and are designed to help professionals build competency and improve practice so they can make important decisions on patient care